Document is current
Any future updates will be listed below
-
Authors
Lietzau, Grazyna https://orcid.org/0000-0001-5119-3082
Ntika, Stelia
Pintana, Hiranya
Tracy, Linda
Klein, Thomas
Nyström, Thomas
Darsalia, Vladimer
Patrone, Cesare
Krizhanovskii, Camilla https://orcid.org/0000-0003-2195-165X
-
Funding
Funding for this research was provided by:
Mats Klebergs Stiftelse
sven och dagmar salens stiftelse
Stockholms Läns Landsting
European Foundation for the Study of Diabetes
Vetenskapsrådet
Diabetesfonden
Hjärt-Lungfonden (20160511)
Svensk förening för diabetologi
Karolinska Institutet
Stiftelsen för Gamla Tjänarinnor
STROKE-Riksförbundet
ALF
Karolinska Institute
- License Information
-
More Information
Article History
Received: 3 December 2020
Accepted: 12 March 2021
First Online: 3 April 2021
Declarations
:
: Work in the Patrone/Nyström’s NeuroCardioMetabol group (<u>)</u> is supported by Boehringer Ingelheim Pharma GmbH & Co. TK is employed at Boehringer Ingelheim Pharma GmbH & Co. KG. TN has received unrestricted grants from AstraZeneca and consultancy fees from Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Merck, and Sanofi-Aventis. The other authors declare that they have no conflicts of interest.
: No.: S7-13, issued by Stockholms södra djurförsöksetiska nämnd.
